HansaBioMed Life Sciences, founded in 2007, is the first company entirely focused on the research in the field of exosomes, extracellular vesicles (EVs) and nanoparticles. Today HansaBioMed collaborates with various international research groups, both Academic and Industrial, and participates in research projects aimed to implement the knowledge on the full potential of the EVs. With our expertise, gathered in over 10 years of activity, we actively work not only to improve the current technologies for EV isolation and characterization but also to investigate new fields of application of the extracellular vesicles. Together with the research activities, Hansabiomed provides its customers with high quality of services and products dedicated to the exosomes and EV research. Our service portfolio includes scalable and automated purification of extracellular vesicles from conditioned media, biofluids or plant extracts, bulk or single EV characterization, biomarker assessment by mass spectrometry and RNA seq. Our catalog of products includes a broad range of purified EVs, tools for EV purification, enrichment and characterization. Our facilities are located in Tallinn (Estonia), in the Technology park Tehnopol. Since 2019, HansaBioMed is part of the Exosomics group. Exosomics is a company located in Siena (Italy), founded in 2011 by the same founders of HansaBioMed with the aim to leverage the EV potential for diagnostic purposes.